Cranial Electrotherapy Stimulation and Acute Stress

Sponsor
Tufts University (Other)
Overall Status
Recruiting
CT.gov ID
NCT06034496
Collaborator
United States Department of Defense (U.S. Fed)
200
1
2
21.6
9.3

Study Details

Study Description

Brief Summary

The goal of this study is to quantify the effects of 20 sessions of Cranial Electrotherapy Stimulation (CES) on measures of acute stress responses in Soldiers. The main question it aims to answer is how 20 sessions of CES will affect Soldiers' biochemical (salivary alpha amylase and cortisol), physiological (e.g., heart rate, heart rate variability, respiration rate), emotional (state anxiety), and behavioral (i.e., cognitive task performance) responses.

  • On Day 1, participants will complete a baseline measure assessing their biochemical, physiological, emotional, and behavioral responses to a stressful lethal force decision making task.

  • In the next four to six weeks, participants will complete 20 CES sessions.

  • Within five days of completing the 20 CES sessions, participants will complete a follow-up measure assessing their biochemical, physiological, emotional, and behavioral responses to the same stressful lethal force decision making task they completed on Day

Researchers will compare the Active CES group to the Sham CES group to see how 20 sessions of Active CES will affect the participants responses to their biochemical, physiological, emotional and behavioral responses relative to the Sham CES group.

Condition or Disease Intervention/Treatment Phase
  • Device: Active CES
  • Device: Sham CES
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Investigator)
Masking Description:
Coded devices with master key kept outside of research team.
Primary Purpose:
Basic Science
Official Title:
Cranial Electrotherapy Stimulation (CES) Influences on Acute Stress Responses
Anticipated Study Start Date :
Sep 13, 2023
Anticipated Primary Completion Date :
Jul 1, 2025
Anticipated Study Completion Date :
Jul 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Active CES

Active Cranial Electrotherapy Stimulation (CES)

Device: Active CES
Active CES group will receive a minimum of 250µA and up to 500µA depending on thresholding, once daily for 20 days (over the course of 4~6 weeks), 20 minutes per day.
Other Names:
  • Alpha-Stim
  • Sham Comparator: Sham CES

    Sham Cranial Electrotherapy Stimulation (CES)

    Device: Sham CES
    Sham CES group will be identical to Active CES group with the exception of the device not administering any electrical current
    Other Names:
  • Alpha-Stim
  • Outcome Measures

    Primary Outcome Measures

    1. Change from baseline in heart rate during stressful lethal force decision making task [Baseline and follow-up session after 20 CES to be completed within 4-6weeks]

      heart rate will be measured in beats per minute.

    2. Change from baseline in respiration rate during stressful lethal force decision making task [Baseline and follow-up session after 20 CES to be completed within 4-6weeks]

      respiration rate will be measured in breaths per minute.

    3. Change from baseline in heart rate variability during stressful lethal force decision making task [Baseline and follow-up session after 20 CES to be completed within 4-6weeks]

      Heart rate variability will be measured in RMSSD.

    4. Change over time in alpha amylase during stressful lethal force decision making task [Baseline and follow-up session after 20 CES completed within 4-6weeks]

      Alpha amylase (IU) will be measured through saliva samples. Saliva samples will be taken at five time points, approximately 20 minute increments during the baseline and follow-up sessions.

    5. Change over time in cortisol during stressful lethal force decision making task [Baseline and follow-up session after 20 CES completed within 4-6weeks]

      Cortisol (ng/dL) will be measured through saliva samples. Saliva samples will be taken at five time points, approximately 20 minute increments during the baseline and follow-up sessions.

    6. Change over time in State Trait Anxiety Inventory (STAI) scores at each session (including CES sessions) from baseline to follow-up [At baseline, at each of the 20 CES sessions completed within 4-6weeks, and at follow-up to be completed within 5 days of last CES]

      STAI assesses both state and trait anxiety separately with each scale ranging from 20 to 80, with higher scores correlating with greater anxiety.

    7. Change from baseline in recognition memory [Baseline and follow-up session after 20 CES completed within 4-6weeks]

      Recognition memory of previously learned targets while ignoring visually similar distractor objects will be measured and evaluated with d prime scores. Higher d prime scores correlate with more accurate responses.

    8. Change from baseline in spatial orientation [Baseline and follow-up session after 20 CES completed within 4-6weeks]

      Spatial orientation task will involve pointing towards a series of distant (out of visible range) landmarks in the virtual environment and estimating distance to those landmarks. Spatial orientation will be calculated using mean absolute angular error. Larger numbers correlate with higher error.

    9. Change from baseline in decision making accuracy [Baseline and follow-up session after 20 CES completed within 4-6weeks]

      Participants will make lethal force decision making by shooting at threatening targets and allowing non-threatening targets to pass. Decision making accuracy will be calculated using d prime. Higher d prime correlates with better accuracy.

    10. Change from baseline in decision making reaction time [Baseline and follow-up session after 20 CES completed within 4-6weeks]

      Participants will make lethal force decision making by shooting at threatening targets and allowing non-threatening targets to pass. Decision making reaction time to shoot at threatening targets will be measured in milliseconds.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 40 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • 18-40 years of age (17-40 if emancipated minor)

    • Can sit and stand freely.

    • Have not used or experienced CES administration in the past.

    • Agree to have their data stored in a repository (database) for future use.

    Exclusion Criteria:
    • Use of prescription medications, other than oral contraceptives

    • Women only:

    1. Pregnant or plan to become pregnant during the study

    2. Nursing

    • History of:
    1. A neurological or psychological disorder (such as depression, anxiety disorders, migraines, cluster headaches, seizures, Post-traumatic stress disorder (PTSD) or panic attacks).

    2. Cardiac disease (including arrhythmia or fast or skipped heart beats).

    3. Implanted medical devices, such as pacemakers.

    4. Hypertension.

    5. Insomnia

    6. Head injury (including neurosurgery, concussion, TBI, skull fracture, hematoma)

    7. Illness that caused brain injury

    8. Any other brain-related condition (such as traumatic brain injury)

    9. Metal in the head (outside of mouth, such as shrapnel, surgical clips, or fragments from welding or metalwork)

    10. Implanted medical device (e.g., pacemaker, insulin pump)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Tufts University Medford Massachusetts United States 02155

    Sponsors and Collaborators

    • Tufts University
    • United States Department of Defense

    Investigators

    • Principal Investigator: Kana Okano, Ph.D., Tufts University

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    Tufts University
    ClinicalTrials.gov Identifier:
    NCT06034496
    Other Study ID Numbers:
    • STUDY00003572
    First Posted:
    Sep 13, 2023
    Last Update Posted:
    Sep 13, 2023
    Last Verified:
    Sep 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Tufts University

    Study Results

    No Results Posted as of Sep 13, 2023